Eurosurveillance banner


Eurosurveillance is planning to publish a special issue on Socio-economic determinants and infections diseases in Europe in spring of 2010. For this reason Eurosurveillance invites interested scientists who have research findings in the area to submit papers for review and possible publication.

The data from 27 European Union countries plus Iceland, Liechtenstein and Norway show that considerable progress has been made in preventing and controlling the disease. The number of newly diagnosed cases and the overall notification rate declined continuously in the past decade, and the notification rate in 2007 was 12% lower than in 2003. In spite of this decline, a total of 84,917 new cases of TB were registered in 2007 and a number of challenges hamper the progress towards the elimination of TB in the EU.

A number of bacterial and viral infections in pregnant women can have serious effects on the unborn child leading to impaired mental and physical health later in life. This week’s issue of Eurosurveillance is dedicated to infectious diseases in pregnancy.

The emergence and spread of antimicrobial resistance (AMR) is a growing problem in many European countries. To mark the very first European Antibiotic Awareness Day, on 18 November, the scientific journal Eurosurveillance runs a series of articles to highlight main aspects of the AMR problem in Europe. They will be published in two issues on 13 and 20 November 2008.

In preparation for the coming influenza season 2008-9, Eurosurveillance publishes a special issue on prevention of influenza by vaccination. Seasonal influenza poses a serious public health threat because of associated serious morbidity and mortality. In Europe, estimates suggest that influenza is responsible for around 40,000 to 220,000 excess deaths, depending on the severity of the epidemic.

Today Eurosurveillance is publishing a special issue dedicated to the widespread advances made in Europe in estimating the real number of newly acquired HIV infections based on an innovative approach called STARHS

To tie in with World Hepatitis Day on 19 May, the scientific journal Eurosurveillance is today publishing a special issue on viral hepatitis, highlighting issues and challenges related to hepatitis B and C.

On 17 April 2008, Eurosurveillance is publishing a special issue with articles on the measles situation in Europe. The publication is linked to European Immunisation Week which runs from 21-27 April.

World Tuberculosis Day on 24 March commemorates the date in 1882 when Robert Koch presented his findings of the causing agent of tuberculosis (TB) – Mycobacterium tuberculosis. In the run up of this day Eurosurveillance publishes a special issue on the situation of TB in Europe.

Today (6 March, 2008), Eurosurveillance, the European peer-reviewed journal of infectious diseases, publishes a special issue on meningococcal disease. It includes two in-depth articles and an editorial by the European Centre for Disease Prevention and Control (ECDC).


In this issue


Home Eurosurveillance Monthly Release  2005: Volume 10/ Issue 11 Article 4 Printer friendly version
Back to Table of Contents
en es fr
Previous Next

Eurosurveillance, Volume 10, Issue 11, 01 November 2005
Surveillance report
Fox rabies in France

Citation style for this article: Toma B. Fox rabies in France. Euro Surveill. 2005;10(11):pii=577. Available online: http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=577

 

B Toma
Ecole nationale vétérinaire, Maisons-Alfort, France


Fox rabies was first recorded in France in March 1968, and remained a problem until 1998. In the course of the first two decades and despite the control measures applied, rabies expanded both in terms of the enzootic surface area and number of cases.
The measures applied consisted of actions aimed at reducing fox population density, the mandatory vaccination of domestic carnivores in the officially infected areas, and use of human prophylaxis.
Following the large scale implementation of oral vaccination of foxes, starting 1989-1990, the rabies front was pushed back and yearly incidence decreased until rabies was eliminated at the end of 1998. The comparison of results obtained during both periods of applying various strategies is spectacular. France remains exposed to the risk from bat rabies on one hand, and from accidental cases of canine rabies imported from enzootic countries, on the other.


 
The period between March 1968 and December 1998 represented three decades of fox rabies in France. Looking back over several years, it is possible to evoke the characteristics of the descriptive epidemiology (evolution in time and space) of this fox rabies ‘invasion’, and the measures applied to control it. After two decades of semi-failures, those measures eventually were successful thanks to the prophylactic ‘revolution’ represented by oral vaccination of foxes against rabies [1].

Descriptive epidemiology of fox rabies in France (1968-1998)
The evolution of the yearly incidence of fox rabies in France is shown in figure 1.


The evolution of the fox rabies front during the years when the enzootics progressed (1968-1990) is shown in figure 2 [3].


From 1968 to 1975, the progression of the fox rabies front was uninterrupted and the increase of incidence was exponential. From 1975, the progression of the front slowed down. Epidemic waves were observed every 3-6 years in the infected area.
Until 1990, the control efforts, which were mainly based on limiting fox populations and vaccination of domestic animals, were unable to control the disease. A retrospective study on 10 years [4] of the efficacy of sanitary control measures on rabies incidence did not show any constant efficacy.
From 1990, the yearly incidence decreased until the complete disappearance of rabies in 1999. The enzootic area progressively shrank northwestwards until it disappeared.
The success of the eradication programme was due to the change in policy against rabies implemented in 1989.

The fight against fox rabies in France
For two decades, rabies prophylactic measures applied to foxes were mainly based on attempts to reduce fox populations using various available means, strongly opposed by ecologists, such as poisoning, rifle shooting, gassing fox dens with chloropicrine, etc.
In France, the first actions ‘on-site’ oral vaccination of foxes were carried out in 1986 along the borders with Belgium and Luxembourg. The results were disappointing, unlike the more satisfying results obtained in Switzerland [5].
In December 1998, the Scientific Commission of the National Federation of Cattle Sanitary groups dedicated its annual meeting to rabies, gathering together specialists from the National Rabies Laboratory (Nancy) and Pasteur Institute (Paris). Vaccination of foxes against rabies was clearly a topic of interest, and proposals were made to implement it on a large scale in France. In 1989, the decision was made at the highest level (by the prime minister) to adopt a strategy to surround the enzootic area by a vaccination belt, followed by an action of forcing back infection towards the north east.
The strategy was defined by the National Rabies Laboratory and the “Entente Interdépartementale de la rage” (ERZ), which also organised and implemented all the campaigns.

The immunity barrier to block the advance of the rabies front was set up in 1989 and 1990, and ran from the Swiss border to the North Sea, covering 54 792 km², nearly 41% of the enzootic area [6].
Vaccination areas were then progressively extended, moving up to the northeastern borders [Figure 3]. The whole enzootic area was covered by the autumn 1992 (192 418 km² treated in the year).


This systematic vaccination policy over the whole enzootic area achieved the elimination of fox rabies within a few years, with the last case being recorded at the end of December 1998.
The rules set up were:
- Vaccination in spring and in autumn in enzootic areas;
- Implementation of three successive vaccination campaigns in free areas after the last recorded case;
- Application on extended areas all in one block with a sanitary cordon representing a rabies-free territory of at least 30 km wide;
- Maintenance of increased alertness (continuous surveillance of rabies by sampling, then analysing suspect animals) in areas considered rabies-free in order to quickly react in case a cluster appears.

The efficacy of oral fox vaccination campaigns was increased thanks to various procedures such as [7] :
- Extra vaccination by distributing baits in front of dens,
- Increase of bait density distributed (number by surface).
The intensive efforts carried out between 1989 and 1998 by the National Rabies Laboratory and the ERZ yielded dramatic results. Every year that followed 1998, safety measures were implemented along the German border. From 1999 to 2003, nine oral vaccination campaigns (with only one campaign in autumn 2003) were performed along the German border in order to avoid recontamination of France.
France, along with other western European countries (such as Belgium, Switzerland and Luxembourg), succeeded in eliminating fox rabies from its territory, thanks to the methodical use of anti-rabies vaccination of foxes [8]. Since 2000, France has been listed as rabies-free according to the OIE criteria. France is faced with two potential rabies risks: on one hand, the risk from bats, although the yearly incidence in recent years (since 1989, year of the first bat rabies diagnosis, 20 bat rabies cases all due to EBLV-1 virus on Eptesicus serotinus have been recorded in France [9]) suggests that the situation has stabilised; and on the other hand, the risk from imported dog rabies, as recently experienced in Southern of France [10]. With the recent tightening of European regulations [11] that now require anti-rabies vaccination for any transport of pets between rabies-free countries, the fear is that illegal importation of young cats and dogs acquired by travellers to rabies enzootic countries (mainly in North Africa) will continue.


References

1. Andral L. et Toma B. – Editorial. Le Point vétérinaire, 1995, 27, 1-3.
2. Bulletin épidémiologique mensuel de la rage animale en France, Centre de Malzéville, 1971-1998, 1-28.
3. Aubert M. – La rage en France et en Europe : évolution récente et perspectives. Le Point vétérinaire, 1995, 27, 13-22.
4. Aubert M. - Control of rabies by wildlife depopulation. International conference on epidemiology control and prevention of rabies in Eastern and Southern Africa, Lusaka, Zambie, June 2-5, 1992, pp 141-152.
5. Steck F., Wandeler A., Bischel P., Capt S. and Schneider L. – Oral immunisation of foxes against rabies; a field study. Zentralblatt für Veterinärmedizin, Reihe B, 1982, 29, 372-396.
6. Aubert M. – Actualité de la rage en France. Méd. Trop., 1997, 57, 45-51.
7. Aubert M. et al. – Rabies in France, The Netherlands, Belgium Luxembourg and Switzerland, in Historical perspective of Rabies in Europe and the Mediterranean Basin. King A.A., Fooks A.R., Aubert M. and Wandeler A.I. eds. OIE, 2004, 362 p.
8. Rabies Bulletin Europe. The oral vaccination of foxes against rabies, 2004, 28(2), 5-8.
9. Rapport sur la rage des chiropters en France métropolitaine, Afssa, 2003, 70 p.
10. Mailles A., Bourhy H., de Valk H, Dacheux L., Servas V., Capek I., Desenclos JC. Human and animal exposure to a rabid dog illegally imported into France, August 2004: update, 15 September Eurosurveillance weekly release 8;38, 16 September 2004 http://www.eurosurveillance.org/ew/2004/040916.asp#3.
11. Règlement CE n° 998/2003 du Parlement européen et du Conseil du 26 mai 2003 concernant les conditions de police sanitaire applicables aux mouvements non commerciaux d’animaux de compagnie, et modifiant la directive 92/65/CEE du Conseil, Journal official de l’Union européenne, 13 juin 2005, L 146/1 – L 146/9.

 



Back to Table of Contents
en es fr
Previous Next

Disclamer:The opinions expressed by authors contributing to Eurosurveillance do not necessarily reflect the opinions of the European Centre for Disease Prevention and Control (ECDC) or the Editorial team or the institutions with which the authors are affiliated. Neither the ECDC nor any person acting on behalf of the ECDC is responsible for the use which might be made of the information in this journal.
Eurosurveillance [ISSN] - ©2008 All rights reserved